Drdgold (DRDGF) Liabilities and Shareholders Equity (2017 - 2025)

Drdgold has reported Liabilities and Shareholders Equity over the past 9 years, most recently at $670.6 million for Q2 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $670.6 million for Q2 2025, up 31.66% from a year ago — trailing twelve months through Jun 2025 was $2.1 billion (up 11.96% YoY), and the annual figure for FY2025 was $670.6 million, up 31.66%.
  • Liabilities and Shareholders Equity reached $670.6 million in Q2 2025 per DRDGF's latest filing, up from $509.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $670.6 million in Q2 2025 and bottomed at $438.4 million in Q2 2023.
  • Median Liabilities and Shareholders Equity over the past 5 years was $456.7 million (2022), compared with a mean of $504.8 million.
  • The largest annual shift saw Liabilities and Shareholders Equity skyrocketed 41.64% in 2021 before it dropped 4.02% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $448.9 million in 2021, then grew by 1.74% to $456.7 million in 2022, then dropped by 4.02% to $438.4 million in 2023, then grew by 16.18% to $509.3 million in 2024, then skyrocketed by 31.66% to $670.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for DRDGF at $670.6 million in Q2 2025, $509.3 million in Q2 2024, and $438.4 million in Q2 2023.